Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience Receives CE Mark for Cystic Fibrosis Test

NEW YORK, Jan. 12 (GenomeWeb News) - The European Union approved Tm Bioscience to market its Tag-It Cystic Fibrosis Kit for diagnostic purposes, the company said yesterday.


Under the CE Mark, the company can market the genetic test to EU countries and other countries that recognize the designation.


The US Food and Drug Administration approved the kit as an in vitro device for diagnostic use.


The test detects and identifies mutations and variants in the cystic fibrosis transmembrane conductance regulator gene in human blood or blood spot specimens.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.